| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 2.09e-13 | 37 | 158 | 10 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 2.82e-13 | 38 | 158 | 10 | GO:0070001 |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 ZSWIM8 TRAF1 MYCBP2 UBR4 KAT6A ZIM2 MYRIP SLC39A4 ZNF385B ZNF318 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ZCCHC2 ZFPM2 ZCCHC14 BMP1 RASGRP1 GLI2 RNF146 SEC24B ERVK-8 ERVK-5 KMT2A ERVK-19 ERVK-24 TOP3A | 7.58e-11 | 891 | 158 | 29 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 ZSWIM8 TRAF1 MYCBP2 UBR4 KAT6A ZIM2 MYRIP SLC39A4 ZNF385B ZNF318 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ZCCHC2 ZFPM2 ZCCHC14 BMP1 RASGRP1 GLI2 RNF146 SEC24B ERVK-8 ERVK-5 KMT2A ERVK-19 ERVK-24 TOP3A | 5.23e-08 | 1189 | 158 | 29 | GO:0046914 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.19e-06 | 11 | 158 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.55e-06 | 14 | 158 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.03e-05 | 21 | 158 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.07e-05 | 46 | 158 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 TWNK BTAF1 ERVK-7 ERVK-10 FAN1 BPTF ERVK-8 NAV2 TOP3A | 4.64e-05 | 262 | 158 | 10 | GO:0140097 |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 BMP1 ERVK-8 ERVK-18 C2 ERVK-19 ERVK-25 ERVK-24 | 1.66e-04 | 430 | 158 | 12 | GO:0004175 |
| GeneOntologyMolecularFunction | histone H3K9 acetyltransferase activity | 1.86e-04 | 3 | 158 | 2 | GO:0043992 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.03e-04 | 37 | 158 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.06e-04 | 15 | 158 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.26e-04 | 38 | 158 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | calcium, potassium:sodium antiporter activity | 6.13e-04 | 5 | 158 | 2 | GO:0008273 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 SPTBN2 OBSCN KRTAP29-1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 DCN ERVK-8 ERVK-18 ERVK-5 ERVK-19 ERVK-25 DMBT1 ERVK-24 MUC6 | 7.11e-04 | 891 | 158 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | peptidase activity | USP53 ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 BMP1 ERVK-8 ERVK-18 C2 ERVK-19 ERVK-25 USP54 ERVK-24 | 7.14e-04 | 654 | 158 | 14 | GO:0008233 |
| GeneOntologyBiologicalProcess | DNA integration | 2.13e-06 | 13 | 156 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | central nervous system development | GAK KIF1A MYCBP2 CENPF SPTBN2 GRN VPS54 ARHGAP35 ATXN1L PITPNM1 SHROOM4 BPTF OTP CDK5R1 GLI2 GLI3 SEC24B LRP1 NAV2 NHEJ1 CPLANE1 ANAPC7 NPAS2 | 3.47e-05 | 1197 | 156 | 23 | GO:0007417 |
| MousePheno | abnormal right lung accessory lobe morphology | 6.40e-06 | 5 | 122 | 3 | MP:0009571 | |
| MousePheno | omphalocele | 6.41e-06 | 53 | 122 | 6 | MP:0003052 | |
| MousePheno | abnormal abdominal wall morphology | 7.17e-06 | 82 | 122 | 7 | MP:0003257 | |
| MousePheno | herniated abdominal wall | 2.40e-05 | 20 | 122 | 4 | MP:0000757 | |
| MousePheno | abnormal body wall morphology | 5.24e-05 | 151 | 122 | 8 | MP:0003385 | |
| MousePheno | abnormal renal tubule epithelium morphology | 5.91e-05 | 48 | 122 | 5 | MP:0009640 | |
| MousePheno | abnormal right lung middle lobe morphology | 7.55e-05 | 2 | 122 | 2 | MP:0009573 | |
| MousePheno | absent right lung accessory lobe | 7.55e-05 | 2 | 122 | 2 | MP:0010824 | |
| MousePheno | abnormal lung lobe morphology | 1.86e-04 | 33 | 122 | 4 | MP:0010975 | |
| MousePheno | abnormal kidney epithelium morphology | 1.88e-04 | 61 | 122 | 5 | MP:0004967 | |
| Domain | zf-CCHC | 2.90e-05 | 23 | 147 | 4 | PF00098 | |
| Domain | CUB | 4.07e-05 | 49 | 147 | 5 | PF00431 | |
| Domain | CUB | 4.49e-05 | 50 | 147 | 5 | SM00042 | |
| Domain | - | 5.44e-05 | 52 | 147 | 5 | 2.60.120.290 | |
| Domain | CUB | 5.97e-05 | 53 | 147 | 5 | PS01180 | |
| Domain | ZnF_C2HC | 7.15e-05 | 55 | 147 | 5 | SM00343 | |
| Domain | Znf_CCHC | 7.15e-05 | 55 | 147 | 5 | IPR001878 | |
| Domain | CUB_dom | 8.50e-05 | 57 | 147 | 5 | IPR000859 | |
| Domain | ZF_CCHC | 1.60e-04 | 35 | 147 | 4 | PS50158 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-18 ERVK-5 ERVK-19 ERVK-25 ERVK-24 | 6.86e-13 | 94 | 160 | 11 | 21542922 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.94e-12 | 5 | 160 | 5 | 12629516 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP53 JCAD SYNRG ARHGAP32 HIVEP2 TTC28 MYCBP2 MLXIP PFKP MAP3K6 ZCCHC14 ZNF106 MTMR4 PTPN13 SEC24B NAV2 KMT2A TNKS1BP1 USP54 PLCH1 PHLDB2 CRTC2 | 8.54e-11 | 861 | 160 | 22 | 36931259 |
| Pubmed | 1.53e-10 | 18 | 160 | 6 | 18664271 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.31e-10 | 4 | 160 | 4 | 10469592 | |
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 7983737 | ||
| Pubmed | SEC16B ARHGAP32 CTTNBP2 SPTBN2 TOGARAM1 ZBTB26 ZCCHC2 ARHGAP35 REXO1 FAN1 SHROOM4 KRBA1 FAT2 PLCH1 MAML3 UNC80 | 1.31e-09 | 493 | 160 | 16 | 15368895 | |
| Pubmed | 1.49e-09 | 12 | 160 | 5 | 14557543 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 SYNRG HIVEP2 MYCBP2 UBR4 KAT6A OBSCN TWNK BTAF1 MLXIP ARHGAP35 ANKHD1 REXO1 GGA3 PCNX2 ZCCHC14 STK10 CDK5R1 NAV2 TNKS1BP1 SNAPC4 FEM1A TOP3A | 1.63e-09 | 1105 | 160 | 23 | 35748872 |
| Pubmed | NRIP1 ZSWIM8 ARHGAP32 TRAF1 KAT6A GRN RUNX1T1 ANKHD1 ATXN1L TXNDC11 ZFPM2 DZIP3 YY1AP1 USP54 KAT6B RAI2 TGS1 | 3.64e-09 | 608 | 160 | 17 | 16713569 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | USP53 NRIP1 HIVEP2 KIF1A MYCBP2 SLC38A9 KAT6A OBSCN MYRIP BARD1 ZNF385B BTAF1 VPS54 ARHGAP35 DNAH1 PCNX2 STK10 BPTF PTPN13 GLI2 SETBP1 LRP1 ANKRD12 KAT6B MAML3 NPAS2 | 4.97e-09 | 1489 | 160 | 26 | 28611215 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SEC16B SYNRG MYCBP2 BTAF1 ZNF318 ARHGAP35 PFKP REXO1 PITPNM1 STK10 BPTF ZNF106 KMT2A YY1AP1 TNKS1BP1 SNAPC4 KAT6B PHLDB2 | 2.11e-08 | 774 | 160 | 18 | 15302935 |
| Pubmed | NRIP1 TTC28 MYCBP2 CENPF ZSCAN4 UBR4 RUSC1 ZNF318 POU5F1B ANKHD1 PTPN13 LRP1 TNKS1BP1 | 8.06e-08 | 418 | 160 | 13 | 34709266 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 10516026 | ||
| Pubmed | TTC28 MYCBP2 TOGARAM1 ARHGAP35 ZCCHC14 SETBP1 NAV2 TNKS1BP1 KAT6B UNC80 | 1.03e-07 | 225 | 160 | 10 | 12168954 | |
| Pubmed | SYNRG GAK TTC28 MYCBP2 SPTBN2 ZNF318 ARHGAP35 ANKHD1 GGA3 BPTF PTPN13 SEC24B KMT2A TNKS1BP1 | 2.84e-07 | 549 | 160 | 14 | 38280479 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 9.49e-07 | 5 | 160 | 3 | 11401426 | |
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 15063128 | ||
| Pubmed | JCAD NRIP1 ZSWIM8 HIVEP2 TTC28 KIF1A MYCBP2 SPTBN2 UBR4 MYRIP VPS54 DCN TXNDC11 FAN1 PTPN13 RCBTB1 LRP1 YY1AP1 USP54 DNAJB2 | 2.06e-06 | 1285 | 160 | 20 | 35914814 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.37e-06 | 184 | 160 | 8 | 32908313 | |
| Pubmed | ARHGAP32 UBR4 PABPC4 TWNK GRN ZNF318 PFKP ANKHD1 ATXN1L INO80D ZFPM2 BPTF KAT2B GLI2 GLI3 SEC24B KMT2A ELAVL2 YY1AP1 USP54 RAI2 | 2.75e-06 | 1429 | 160 | 21 | 35140242 | |
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 18682553 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | USP53 JCAD ARHGAP32 UBR4 GLIS3 GGA3 STK10 ZNF469 GLI2 SETBP1 CRTC2 | 5.42e-06 | 430 | 160 | 11 | 35044719 |
| Pubmed | SUMOylation of Tr2 orphan receptor involves Pml and fine-tunes Oct4 expression in stem cells. | 7.87e-06 | 9 | 160 | 3 | 17187077 | |
| Pubmed | Gli3 null mice display glandular overgrowth of the developing stomach. | 7.87e-06 | 9 | 160 | 3 | 16247775 | |
| Pubmed | 8.10e-06 | 28 | 160 | 4 | 33953184 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ZSWIM8 ARHGAP32 KIF1A MLXIP ZCCHC2 ATXN1L GRAMD1B SHROOM4 NAV2 ERVK-25 CPLANE1 UNC80 | 1.04e-05 | 552 | 160 | 12 | 10737800 |
| Pubmed | CD spectra show the relational style between Zic-, Gli-, Glis-zinc finger protein and DNA. | 1.12e-05 | 10 | 160 | 3 | 18298960 | |
| Pubmed | 1.12e-05 | 10 | 160 | 3 | 12970426 | ||
| Pubmed | ZSWIM8 KIF1A MYCBP2 CENPF SPTBN2 UBR4 PABPC4 ZNF318 PFKP ANKHD1 BPTF KMT2A TNKS1BP1 | 1.13e-05 | 653 | 160 | 13 | 22586326 | |
| Pubmed | Acetylation of HIV-1 integrase by p300 regulates viral integration. | 1.53e-05 | 11 | 160 | 3 | 16096645 | |
| Pubmed | ZSWIM8 TTC28 KAT6A ZNF318 ANKHD1 INO80D BPTF ZNF469 KAT2B GLI3 CAPRIN2 LRP1 USP54 KAT6B ANAPC7 UNC80 PHLDB2 | 1.67e-05 | 1116 | 160 | 17 | 31753913 | |
| Pubmed | 1.97e-05 | 71 | 160 | 5 | 33541421 | ||
| Pubmed | Congenital diaphragmatic hernia: comparison of animal models and relevance to the human situation. | 2.04e-05 | 12 | 160 | 3 | 19325248 | |
| Pubmed | STARD13 MYCBP2 ZSCAN4 UBR4 PABPC4 TWNK GRN GGA3 ZNF106 MTMR4 LRP1 DNAJB2 | 2.04e-05 | 591 | 160 | 12 | 15231748 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28511025 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22219627 | ||
| Pubmed | The low density lipoprotein receptor-related protein functions as an endocytic receptor for decorin. | 2.10e-05 | 2 | 160 | 2 | 16936287 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 17283082 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 10693670 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 39505971 | ||
| Pubmed | Differential effects of GLI2 and GLI3 in regulating cervical cancer malignancy in vitro and in vivo. | 2.10e-05 | 2 | 160 | 2 | 29967343 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20154143 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24150941 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25656619 | ||
| Pubmed | Normal exon copy number of the GLI2 and GLI3 genes in patients with esophageal atresia. | 2.10e-05 | 2 | 160 | 2 | 23442119 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 2.10e-05 | 2 | 160 | 2 | 9460924 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27185879 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27129268 | ||
| Pubmed | Adult Gli2+/-;Gli3Δ699/+ Male and Female Mice Display a Spectrum of Genital Malformation. | 2.10e-05 | 2 | 160 | 2 | 27814383 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 34808502 | ||
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 2.10e-05 | 2 | 160 | 2 | 11672541 | |
| Pubmed | Decorin is processed by three isoforms of bone morphogenetic protein-1 (BMP1). | 2.10e-05 | 2 | 160 | 2 | 20026052 | |
| Pubmed | A study on etiology of incontinence in double knockout mouse model. | 2.10e-05 | 2 | 160 | 2 | 36272934 | |
| Pubmed | HIVEP2 KIF1A ZNF318 ZCCHC14 OTP RCBTB1 GLI2 GLI3 RNF146 KMT2A KAT6B MAML3 TOP3A | 2.66e-05 | 709 | 160 | 13 | 22988430 | |
| Pubmed | 3.19e-05 | 263 | 160 | 8 | 34702444 | ||
| Pubmed | STARD13 CACNA1E CENPF SPTBN2 UBR4 BIVM PABPC4 SKIDA1 MYRIP TWNK ZNF318 PFKP BPTF CAPRIN2 NAV2 KMT2A NGLY1 PLCH1 ANAPC7 | 3.83e-05 | 1442 | 160 | 19 | 35575683 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 27093457 | ||
| Pubmed | Murine models of VACTERL syndrome: Role of sonic hedgehog signaling pathway. | 6.29e-05 | 3 | 160 | 2 | 11172440 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 26010061 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 11509661 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 9971820 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 24121003 | ||
| Pubmed | Colorectal cancer susceptibility variants alter risk of breast cancer in a Chinese Han population. | 6.29e-05 | 3 | 160 | 2 | 24338422 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 23063713 | ||
| Pubmed | Zscan4: a novel gene expressed exclusively in late 2-cell embryos and embryonic stem cells. | 6.29e-05 | 3 | 160 | 2 | 17553482 | |
| Pubmed | Gli family members are differentially expressed during the mitotic phase of spermatogenesis. | 6.29e-05 | 3 | 160 | 2 | 9178901 | |
| Pubmed | Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. | 6.29e-05 | 3 | 160 | 2 | 8378770 | |
| Pubmed | MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain. | 6.29e-05 | 3 | 160 | 2 | 36754959 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 8387379 | ||
| Pubmed | Positive regulation of Hedgehog signaling via phosphorylation of GLI2/GLI3 by DYRK2 kinase. | 6.29e-05 | 3 | 160 | 2 | 38968120 | |
| Pubmed | Unique and complimentary activities of the Gli transcription factors in Hedgehog signaling. | 6.29e-05 | 3 | 160 | 2 | 16571352 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 22203668 | ||
| Pubmed | Different expression patterns of Gli1-3 in mouse embryonic maxillofacial development. | 6.29e-05 | 3 | 160 | 2 | 22178118 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 25814825 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 19955409 | ||
| Pubmed | A novel modulatory mechanism of transforming growth factor-beta signaling through decorin and LRP-1. | 6.29e-05 | 3 | 160 | 2 | 17485468 | |
| Pubmed | Sonic hedgehog through Gli2 and Gli3 is required for the proper development of placental labyrinth. | 6.29e-05 | 3 | 160 | 2 | 25695606 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 14581481 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | STARD13 SEC16B CTTNBP2 C19orf67 BIVM PABPC4 SKIDA1 KDM4E MFRP DCN PITPNM1 ZCCHC14 CBLIF ZNF106 KAT2B CAPRIN2 SNAPC4 | 6.32e-05 | 1242 | 160 | 17 | 30973865 |
| Pubmed | 8.77e-05 | 19 | 160 | 3 | 29941866 | ||
| Pubmed | 8.77e-05 | 19 | 160 | 3 | 23912999 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NRIP1 SYNRG ZSWIM8 GAK TTC28 ZNF318 ZCCHC2 RIMBP3 YY1AP1 TNKS1BP1 TOP3A | 9.44e-05 | 588 | 160 | 11 | 38580884 |
| Pubmed | 1.20e-04 | 407 | 160 | 9 | 12693553 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 9027508 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 22281533 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 27793025 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 29429990 | ||
| Pubmed | Expression profile of Gli family members and Shh in normal and mutant mouse limb development. | 1.25e-04 | 4 | 160 | 2 | 9438426 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 8150204 | ||
| Pubmed | Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. | 1.25e-04 | 4 | 160 | 2 | 23932781 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 32080306 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 24952464 | ||
| Pubmed | Recognition of accessory protein motifs by the gamma-adaptin ear domain of GGA3. | 1.25e-04 | 4 | 160 | 2 | 12858162 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 21880731 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 10531011 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 33431365 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 17980166 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 9006072 | ||
| Interaction | YWHAH interactions | USP53 JCAD NRIP1 SYNRG ARHGAP32 HIVEP2 TTC28 MYCBP2 TWNK MLXIP ATXN1L MAP3K6 ZCCHC14 ZNF106 MTMR4 PTPN13 SEC24B NAV2 KMT2A TNKS1BP1 USP54 PLCH1 PHLDB2 CRTC2 | 1.26e-06 | 1102 | 146 | 24 | int:YWHAH |
| Interaction | TOP3B interactions | EPHB4 SYNRG HIVEP2 MYCBP2 CENPF SPTBN2 UBR4 KAT6A OBSCN TWNK GRN BTAF1 MLXIP ARHGAP35 PFKP ANKHD1 REXO1 GGA3 PCNX2 ZCCHC14 STK10 CDK5R1 SEC24B NAV2 TNKS1BP1 SNAPC4 FEM1A TOP3A | 2.06e-06 | 1470 | 146 | 28 | int:TOP3B |
| Interaction | EGLN3 interactions | JCAD ZSWIM8 ARHGAP32 MYCBP2 CENPF UBR4 BTAF1 ZNF318 ANKHD1 ZFPM2 ZCCHC14 ZNF106 PTPN13 GLI2 GLI3 SEC24B TNKS1BP1 PRR14L USP54 PLCH1 FEM1A ANAPC7 TOP3A CRTC2 TGS1 | 6.39e-06 | 1296 | 146 | 25 | int:EGLN3 |
| Interaction | CELA1 interactions | 2.51e-05 | 24 | 146 | 4 | int:CELA1 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 7.26e-05 | 16 | 94 | 3 | 66 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 8.78e-05 | 17 | 94 | 3 | 486 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | HIVEP2 ZSCAN4 GLIS3 ZIM2 ZBTB26 ZNF318 ZFPM2 ZNF106 ZNF469 KLF1 GLI2 GLI3 | 3.39e-04 | 718 | 94 | 12 | 28 |
| GeneFamily | PHD finger proteins | 1.24e-03 | 90 | 94 | 4 | 88 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.24e-03 | 50 | 94 | 3 | 721 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | NRIP1 HIVEP2 CENPF KAT6A TOGARAM1 ZNF318 ZCCHC14 BPTF FAT2 KAT6B NPAS2 | 1.17e-06 | 300 | 148 | 11 | M8702 |
| Coexpression | GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN | 2.15e-06 | 200 | 148 | 9 | M9272 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | HIVEP2 KIF1A MYCBP2 GLIS3 TOGARAM1 ZNF318 ARHGAP35 RUNX1T1 ZCCHC14 ZNF106 RASGRP1 KAT2B CDK5R1 SETBP1 NAV2 ANKRD12 KAT6B UNC80 | 6.88e-06 | 946 | 148 | 18 | M39169 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STARD13 NRIP1 HIVEP2 TTC28 MYCBP2 CENPF KAT6A BARD1 TOGARAM1 BTAF1 ARHGAP35 STK10 BPTF PTPN13 SEC24B KAT6B MYBL1 | 7.25e-06 | 856 | 148 | 17 | M4500 |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP | 1.69e-05 | 197 | 148 | 8 | M4980 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP | 1.82e-05 | 199 | 148 | 8 | M5009 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SYNRG TRAF1 HIVEP2 MYCBP2 UBR4 KAT6A RCSD1 BTAF1 ARHGAP35 IL18RAP INO80D PCNX2 STK10 BPTF RASGRP1 KAT2B DZIP3 KMT2A NGLY1 EDEM1 KAT6B MYBL1 | 3.41e-05 | 1492 | 148 | 22 | M40023 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CACNA1E KIF1A MYCBP2 BIVM RUSC1 ZNF318 ARHGAP35 PFKP RUNX1T1 CSMD2 ZFPM2 OTP CDK5R1 FAT2 RNF146 CAPRIN2 ELAVL2 ANKRD12 | 5.44e-05 | 1106 | 148 | 18 | M39071 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | TRAF1 GAK UBR4 CLEC7A RUSC1 GRN ATXN1L IL18RAP REXO1 GGA3 DNAH1 PITPNM1 STK10 KRBA1 SMCR5 TOP3A | 5.55e-05 | 905 | 148 | 16 | M40865 |
| Coexpression | GSE25677_MPL_VS_R848_STIM_BCELL_UP | 6.13e-05 | 174 | 148 | 7 | M8186 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | STARD13 NRIP1 HIVEP2 MYCBP2 CENPF KAT6A BARD1 BPTF SEC24B KAT6B MYBL1 | 7.17e-05 | 466 | 148 | 11 | M13522 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | CACNA1E SPTBN2 OBSCN PFKP RUNX1T1 BPTF CDK5R1 KMT2A ELAVL2 SNAPC4 | 7.66e-05 | 389 | 148 | 10 | M39102 |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | USP53 ADAMTSL1 TTC28 GLIS3 RUNX1T1 DCN ZFPM2 GLI3 SETBP1 NAV2 PHLDB2 | 3.55e-11 | 185 | 149 | 11 | a5aebf2b9b05b550d021272731d68af9a6b1229d |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | USP53 TTC28 GLIS3 RUNX1T1 CSMD2 DCN ZFPM2 GLI2 GLI3 SETBP1 PHLDB2 | 6.98e-11 | 197 | 149 | 11 | fb847f2277609c31fffcdf49517243ce0684facf |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-08 | 194 | 149 | 9 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-08 | 194 | 149 | 9 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.26e-08 | 197 | 149 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.61e-07 | 190 | 149 | 8 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.61e-07 | 190 | 149 | 8 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-07 | 191 | 149 | 8 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-07 | 191 | 149 | 8 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-07 | 192 | 149 | 8 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.83e-07 | 192 | 149 | 8 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 2.83e-07 | 192 | 149 | 8 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-07 | 192 | 149 | 8 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 2.94e-07 | 193 | 149 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.94e-07 | 193 | 149 | 8 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-07 | 194 | 149 | 8 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 3.06e-07 | 194 | 149 | 8 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.18e-07 | 195 | 149 | 8 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.18e-07 | 195 | 149 | 8 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.44e-07 | 197 | 149 | 8 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-07 | 198 | 149 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.58e-07 | 198 | 149 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.58e-07 | 198 | 149 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.86e-07 | 200 | 149 | 8 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.86e-07 | 200 | 149 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.10e-06 | 175 | 149 | 7 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.10e-06 | 175 | 149 | 7 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.27e-06 | 177 | 149 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-06 | 179 | 149 | 7 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-06 | 184 | 149 | 7 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-06 | 184 | 149 | 7 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.93e-06 | 184 | 149 | 7 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.04e-06 | 185 | 149 | 7 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-06 | 186 | 149 | 7 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.27e-06 | 187 | 149 | 7 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-06 | 188 | 149 | 7 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.38e-06 | 188 | 149 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-06 | 189 | 149 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.51e-06 | 122 | 149 | 6 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-06 | 190 | 149 | 7 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-06 | 190 | 149 | 7 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-06 | 190 | 149 | 7 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 191 | 149 | 7 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 191 | 149 | 7 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 191 | 149 | 7 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 191 | 149 | 7 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.75e-06 | 191 | 149 | 7 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.75e-06 | 191 | 149 | 7 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.75e-06 | 191 | 149 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 191 | 149 | 7 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-06 | 192 | 149 | 7 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.89e-06 | 192 | 149 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.89e-06 | 192 | 149 | 7 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 3.89e-06 | 192 | 149 | 7 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-06 | 193 | 149 | 7 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.02e-06 | 193 | 149 | 7 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.02e-06 | 193 | 149 | 7 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.16e-06 | 194 | 149 | 7 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.16e-06 | 194 | 149 | 7 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.30e-06 | 195 | 149 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-06 | 195 | 149 | 7 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 4.30e-06 | 195 | 149 | 7 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 195 | 149 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 195 | 149 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.45e-06 | 196 | 149 | 7 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | control-immature_Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.45e-06 | 196 | 149 | 7 | e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.45e-06 | 196 | 149 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-06 | 197 | 149 | 7 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.76e-06 | 198 | 149 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.76e-06 | 198 | 149 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.76e-06 | 198 | 149 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.76e-06 | 198 | 149 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 4.92e-06 | 199 | 149 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.08e-06 | 200 | 149 | 7 | be9a43acc2f926b9433ab3f018b911b03896a924 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.08e-06 | 200 | 149 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.08e-06 | 200 | 149 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.08e-06 | 200 | 149 | 7 | 02c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.08e-06 | 200 | 149 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.08e-06 | 200 | 149 | 7 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.08e-06 | 200 | 149 | 7 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.11e-05 | 149 | 149 | 6 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.05e-05 | 166 | 149 | 6 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 169 | 149 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 174 | 149 | 6 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 175 | 149 | 6 | 1b35acece23712ab7e3f92d9d68266efd38b3ef5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.75e-05 | 175 | 149 | 6 | 06af6629766e2054e6995e8cdb3907658fec49d3 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 175 | 149 | 6 | a9f88054e2c28d604c65ed785f63021aadb7f4c8 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.84e-05 | 176 | 149 | 6 | dca70f309af24421f8dc708cbd88512814b8e79e | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.84e-05 | 176 | 149 | 6 | 3c76a5c4ca2b378667cb155fbb9675519572b35d | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 178 | 149 | 6 | 41745a589567ca5ea6d06331f4c8da03595b5f5c | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 178 | 149 | 6 | eb940dd64c973f68bcaad6069d3bd56383329db5 | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 3.22e-05 | 180 | 149 | 6 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.22e-05 | 180 | 149 | 6 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 3.22e-05 | 180 | 149 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.22e-05 | 180 | 149 | 6 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.43e-05 | 182 | 149 | 6 | 1e2149b222a3e9f64841aed45288a6f29394e7b0 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.43e-05 | 182 | 149 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.43e-05 | 182 | 149 | 6 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.65e-05 | 184 | 149 | 6 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.65e-05 | 184 | 149 | 6 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | NRIP1 HIVEP2 GRAMD1B BPTF GLI3 SEC24B NAV2 ANKRD12 KAT6B NPAS2 | 2.08e-07 | 171 | 150 | 10 | 7535_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.50e-06 | 175 | 150 | 9 | 6316_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.15e-06 | 180 | 150 | 9 | 4541_DN | |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 5.56e-06 | 193 | 150 | 9 | 5271_UP | |
| Drug | Domperidone maleate; Down 200; 7.4uM; MCF7; HT_HG-U133A | 7.13e-06 | 199 | 150 | 9 | 5701_DN | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | EPHB4 HIVEP2 INO80D PITPNM1 PCNX2 ZCCHC14 GPR75 PRR14L TOP3A | 7.13e-06 | 199 | 150 | 9 | 2725_DN |
| Disease | unipolar depression, depressive symptom measurement | 7.69e-06 | 26 | 145 | 4 | EFO_0003761, EFO_0007006 | |
| Disease | serum gamma-glutamyl transferase measurement | JCAD SEC16B ICE2 GLIS3 TNFRSF6B TWNK ARHGAP35 SLCO1B7 TRIL BPTF KAT2B SLC24A4 NAV2 KMT2A YY1AP1 MUC6 | 1.17e-05 | 914 | 145 | 16 | EFO_0004532 |
| Disease | waist-hip ratio | JCAD SEC16B TTC28 MYCBP2 SLC38A9 ZNF318 POU5F1B BPTF KLLN NOTUM GLI3 RNF146 SETBP1 CAPRIN2 MAML3 PHLDB2 NPAS2 | 1.15e-04 | 1226 | 145 | 17 | EFO_0004343 |
| Disease | Schizophrenia | NRIP1 ARHGAP32 SPTBN2 GRN CSMD2 PITPNM1 CBLIF CDK5R1 RCBTB1 ERVK-8 LRP1 KMT2A ELAVL2 NPAS2 | 1.21e-04 | 883 | 145 | 14 | C0036341 |
| Disease | cortical thickness | CTTNBP2 MYCBP2 SPTBN2 GLIS3 ZNF385B ZNF318 ARHGAP35 RUNX1T1 ZNF106 ZNF469 GLI3 LRP1 NAV2 KMT2A ELAVL2 PLCH1 | 1.22e-04 | 1113 | 145 | 16 | EFO_0004840 |
| Disease | Exudative retinopathy | 1.43e-04 | 4 | 145 | 2 | C0154832 | |
| Disease | testosterone measurement | STARD13 TTC28 ICE2 PABPC4 GLIS3 ZNF385B ZNF318 REXO1 ZFPM2 GGA3 GRAMD1B SHROOM4 KAT2B C2 YY1AP1 TNKS1BP1 SMCR5 | 1.83e-04 | 1275 | 145 | 17 | EFO_0004908 |
| Disease | depressive symptom measurement | 2.70e-04 | 426 | 145 | 9 | EFO_0007006 | |
| Disease | Hypermetropia, Myopia | 3.55e-04 | 189 | 145 | 6 | HP_0000540, HP_0000545 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 3.66e-04 | 352 | 145 | 8 | EFO_0007014 | |
| Disease | cognitive function measurement, self reported educational attainment | 3.87e-04 | 355 | 145 | 8 | EFO_0004784, EFO_0008354 | |
| Disease | pleckstrin homology domain-containing family A member 1 measurement | 4.96e-04 | 7 | 145 | 2 | EFO_0802873 | |
| Disease | wellbeing measurement | CACNA1E CTTNBP2 HIVEP2 GLIS3 ZBTB26 VPS54 ZCCHC14 BPTF KMT2A ELAVL2 MAML3 | 6.46e-04 | 692 | 145 | 11 | EFO_0007869 |
| Disease | Disorder of eye | 6.51e-04 | 212 | 145 | 6 | C0015397 | |
| Disease | Congenital Amaurosis of Retinal Origin | 6.59e-04 | 8 | 145 | 2 | C3540662 | |
| Disease | coronary aneurysm | 6.78e-04 | 35 | 145 | 3 | EFO_1000881 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 8.44e-04 | 9 | 145 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | EPHB4 NRIP1 CENPF UBR4 OBSCN BARD1 ZNF318 MAP3K6 GGA3 ZCCHC14 BMP1 SETBP1 USP54 KAT6B | 8.62e-04 | 1074 | 145 | 14 | C0006142 |
| Disease | corpus callosum anterior volume measurement | 9.33e-04 | 39 | 145 | 3 | EFO_0010295 | |
| Disease | intraocular pressure measurement | 9.64e-04 | 509 | 145 | 9 | EFO_0004695 | |
| Disease | Inherited neuropathies | 1.01e-03 | 40 | 145 | 3 | C0598589 | |
| Disease | Microphthalmos | 1.28e-03 | 11 | 145 | 2 | C0026010 | |
| Disease | interleukin 1 receptor-like 1 measurement | 1.28e-03 | 11 | 145 | 2 | EFO_0008168 | |
| Disease | cup-to-disc ratio measurement | 1.34e-03 | 430 | 145 | 8 | EFO_0006939 | |
| Disease | reading and spelling ability | 1.40e-03 | 166 | 145 | 5 | EFO_0005301 | |
| Disease | Adenoid Cystic Carcinoma | 1.52e-03 | 100 | 145 | 4 | C0010606 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.53e-03 | 12 | 145 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | gastroesophageal reflux disease | 1.58e-03 | 101 | 145 | 4 | EFO_0003948 | |
| Disease | Leukemia, Myelocytic, Acute | 1.68e-03 | 173 | 145 | 5 | C0023467 | |
| Disease | corneal resistance factor | 1.80e-03 | 451 | 145 | 8 | EFO_0010067 | |
| Disease | Abnormality of refraction | JCAD NRIP1 ARHGAP32 ADAMTSL1 GLIS3 DCN GRAMD1B SLC24A4 RCBTB1 GLI3 | 1.87e-03 | 673 | 145 | 10 | HP_0000539 |
| Disease | Small cell carcinoma of lung | 2.40e-03 | 54 | 145 | 3 | C0149925 | |
| Disease | interleukin 18 receptor 1 measurement | 2.41e-03 | 15 | 145 | 2 | EFO_0008178 | |
| Disease | unipolar depression | JCAD CACNA1E ADAMTSL1 CTTNBP2 HIVEP2 ZFPM2 CRB1 ZCCHC14 TRIL BPTF RASGRP1 KRBA1 ELAVL2 MAML3 | 2.54e-03 | 1206 | 145 | 14 | EFO_0003761 |
| Disease | C-reactive protein measurement | SEC16B ZSWIM8 PABPC4 TNFRSF6B ZCCHC2 IL18RAP ZFPM2 BPTF ZNF106 ZNF469 RNF146 TNKS1BP1 SNAPC4 MAML3 | 2.54e-03 | 1206 | 145 | 14 | EFO_0004458 |
| Disease | Polydactyly | 2.70e-03 | 117 | 145 | 4 | C0152427 | |
| Disease | Leber congenital amaurosis | 2.75e-03 | 16 | 145 | 2 | cv:C0339527 | |
| Disease | FEV/FEC ratio | STARD13 JCAD MGAM CTTNBP2 HIVEP2 PABPC4 SKIDA1 GLIS3 RUNX1T1 ZNF106 LRP1 NAV2 DMBT1 PHLDB2 | 2.99e-03 | 1228 | 145 | 14 | EFO_0004713 |
| Disease | Acute Myeloid Leukemia, M1 | 3.42e-03 | 125 | 145 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 3.42e-03 | 125 | 145 | 4 | C1879321 | |
| Disease | ischemia (biomarker_via_orthology) | 3.48e-03 | 18 | 145 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | Myeloid Leukemia | 3.48e-03 | 18 | 145 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 3.48e-03 | 18 | 145 | 2 | C0023466 | |
| Disease | birth weight | 3.68e-03 | 399 | 145 | 7 | EFO_0004344 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 3.88e-03 | 19 | 145 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 3.88e-03 | 19 | 145 | 2 | C2936783 | |
| Disease | Alzheimer's disease (is_implicated_in) | 4.16e-03 | 132 | 145 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | central corneal thickness | 4.34e-03 | 309 | 145 | 6 | EFO_0005213 | |
| Disease | eye colour measurement | 4.54e-03 | 218 | 145 | 5 | EFO_0009764 | |
| Disease | Antimigraine preparation use measurement | 4.74e-03 | 21 | 145 | 2 | EFO_0009939 | |
| Disease | disease | 4.74e-03 | 21 | 145 | 2 | EFO_0000408 | |
| Disease | cognitive function measurement | CACNA1E SEC16B HTR1B TTC28 ZCCHC2 RUNX1T1 ZFPM2 ZCCHC14 GLI3 SETBP1 ELAVL2 C2 MAML3 NPAS2 BAALC | 4.75e-03 | 1434 | 145 | 15 | EFO_0008354 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PQANLSSAPSQNCSA | 21 | P28222 | |
| GQTQSCPSAQVSPAV | 166 | O42043 | |
| SGQTQSCPSAQVSPA | 276 | O71037 | |
| SGQTQSCPSAQVSPA | 276 | Q902F8 | |
| GQTQSCPSAQVSPAV | 276 | Q9UKH3 | |
| SCANLSTFAQPPPAQ | 91 | Q15078 | |
| SFCSQPSVISSPQIN | 241 | Q99728 | |
| TATSCNDPGIPQNGS | 1381 | Q7Z408 | |
| CLTESSNSPHPQQSQ | 2206 | Q15878 | |
| SGNNSVGAIQCPDSQ | 116 | P28799 | |
| PTENNTSVGPVSNLC | 601 | O95267 | |
| CSPQTGPAQLETSSE | 381 | Q6JBY9 | |
| SPCLPDSTSLSAGNN | 91 | Q86UB2 | |
| CPNSNIPDQESSLQS | 1436 | Q6UB98 | |
| NTSTPSCQSTNGQPQ | 91 | P13497 | |
| SSSVGPAEAQPQTAQ | 2386 | Q12830 | |
| TPEQGVQRSCSSQSG | 56 | Q3KR37 | |
| APVNGTQTAKNCTDP | 66 | Q8NFF2 | |
| SNCLGTGDNQSTLVP | 51 | Q8NDN9 | |
| PQEAPCSSSTIHNNL | 141 | Q9Y5P3 | |
| VERPPSSSQQLAQCS | 1756 | Q8WYB5 | |
| ASTSQDASQCQPSPD | 651 | Q99743 | |
| TGNSASTPQSQCLPS | 86 | Q9UJX3 | |
| QQESGVSPSPQSTCG | 131 | Q9BY79 | |
| VGVESNSNGASPEPC | 101 | Q06416 | |
| APQPGPQNSSCATLS | 261 | Q6W4X9 | |
| TDSCQSGGVPTAVQN | 491 | Q13310 | |
| PSLSCQSDAQSPAVT | 176 | O95256 | |
| PTSCSQNPQPGDSRS | 406 | A5PL33 | |
| SPGGQSSCSSQQSPI | 706 | P10071 | |
| ESEPNSPQTQDKGCQ | 86 | P49901 | |
| GSASPAVAELCQNTP | 11 | Q96IV0 | |
| PASSPANCAVQSPQT | 406 | Q96JK9 | |
| QPCPANSHSNTIGSA | 286 | P54760 | |
| SSLEQPNAGSSSPAC | 401 | Q92831 | |
| SSSLANQQLPPACGA | 106 | Q06455 | |
| ESNATCSARTCPPNQ | 926 | Q07954 | |
| GLADSAPSCPQNVNI | 16 | P06681 | |
| NSNSVSQASCAPPSQ | 586 | P0C7T5 | |
| VSGCSTNNLNNPPFT | 541 | O43451 | |
| AGQNQPAEPDASACT | 1106 | Q9P266 | |
| LNNPCTSTQEPTEGL | 766 | Q8WW38 | |
| SEQCSALPRPVSTQN | 1646 | Q8N6G6 | |
| ANSTTQSQTFPCPQA | 936 | O95382 | |
| QSQDHTSTGPACTQP | 641 | A6NKB5 | |
| LSASSCNNLNQPEPS | 4106 | Q9NYQ8 | |
| NSIQSNCSVPFTPVD | 31 | Q9H1B4 | |
| ATPDTPACVVSLNGN | 336 | Q01813 | |
| NNNISVVGSSDFCPP | 301 | P07585 | |
| NLTAQCPTQPVSSGH | 376 | B2RXH2 | |
| SAFPTCQSNGPVLNT | 56 | P48552 | |
| QTPAAPLDGANVSCS | 341 | Q8NCW0 | |
| LPDSEGNSQCSNQGT | 311 | Q9NZ52 | |
| PSTISGALNQFPQSC | 1256 | P10070 | |
| QRNPNPSCAAAETGA | 101 | B2CW77 | |
| TQNSEICSGQAPTPD | 661 | Q96RR1 | |
| SQCQTPGSTASSEPV | 841 | A7KAX9 | |
| SGQTQSCPSAQVSPA | 1036 | P63135 | |
| VSNVNCVSPSHSPSQ | 1096 | Q86Y13 | |
| SQEESSPCNLQPVNS | 491 | O95800 | |
| CNFPESSQNSPTGTP | 776 | Q9NYA4 | |
| DATLSCQIVGNPTPQ | 26 | Q5VST9 | |
| NPSCPTVRDQFTGQE | 446 | Q6P988 | |
| QSSVQPAANCSIKSP | 1621 | Q92794 | |
| CPNSGQASPCASEQS | 681 | Q9HAP2 | |
| QASPCASEQSPSPQS | 686 | Q9HAP2 | |
| PSPQSPQNNCSGKSD | 696 | Q9HAP2 | |
| QDPGSTCPSFNTVRQ | 431 | P87889 | |
| QDPGSTCPSFNTVRQ | 431 | Q9YNA8 | |
| QDPGSTCPSFNTVRQ | 431 | P62683 | |
| QDPGSACPSFNTVRQ | 431 | P63145 | |
| QDPGSTCPSFNTVRQ | 431 | Q7LDI9 | |
| QDPGSTCPSFNTVRQ | 431 | P63130 | |
| QDPGSTCPSFNTVRQ | 431 | P62685 | |
| QDPGSTCPSFNTVRQ | 431 | P63126 | |
| VIANESAPPNLCGTS | 351 | O43826 | |
| PSSGNNSQPCSNPDL | 966 | O14976 | |
| QDPGSTCPSFNTVRQ | 431 | P62684 | |
| QGPECSSAPAVQVGT | 16 | Q9P2D7 | |
| GQASVGNQTNTACSP | 611 | Q659A1 | |
| QTQSSCSVPSAQEPL | 21 | P27352 | |
| PQTCALAPSEASGAQ | 91 | Q13351 | |
| CVTCPVPTQSGQENS | 936 | O14981 | |
| AAQSADVSLNPCNTP | 131 | P49454 | |
| TQSPVTFQKGSNAPC | 3071 | Q9H799 | |
| GQTQSCPSAQVSPAV | 166 | P61566 | |
| SGQTQSCPSAQVSPA | 276 | P61570 | |
| SGQTQSCPSAQVSPA | 276 | Q69384 | |
| GQTQSCPSAQVSPAV | 166 | P61567 | |
| AATPGLNQPACSDSS | 641 | Q8WZ74 | |
| SGGTQVQQTPASCPL | 231 | P25686 | |
| QQPGLPSQSCSVQSS | 506 | Q53ET0 | |
| PPASQVSTACNQISP | 11 | Q8NEA6 | |
| EDPSTSQGCAQPQGA | 256 | Q9BSK4 | |
| EDTGQSPANSCPQIQ | 266 | A6NJJ6 | |
| TNCETQCPNPQSLSS | 81 | Q8WXS3 | |
| NQSFTTASTQTPPQC | 791 | Q6IMN6 | |
| GQTQSCPSAQVSPAV | 276 | P61565 | |
| GQTQSCPSAQVSPAV | 166 | Q9HDB8 | |
| SNGPTCNNTANGPTT | 6 | Q12926 | |
| NGPTTINNNCSSPVD | 16 | Q12926 | |
| TGVPPDTNNETCTAG | 291 | Q92611 | |
| QGSVCKSPQPQNTSL | 226 | Q53TQ3 | |
| TDSPGPSQISNAAVQ | 3051 | Q03164 | |
| VTCQESCQPSIGAPS | 46 | A8MX34 | |
| SGQTQSCPSAQVSPA | 276 | Q902F9 | |
| SNPCQGSATCVNTPG | 76 | P82279 | |
| DAGVICSASQSQPTP | 1216 | Q9UGM3 | |
| NNNPTITVADSLSCP | 286 | O95487 | |
| STNNSNPVICPSAGS | 246 | Q8NBW4 | |
| TCNGGNSEAVPLTSP | 421 | P10243 | |
| SADEVNNNTCSAVPP | 956 | Q12756 | |
| SVGSCSQPALTPNDS | 1991 | Q12923 | |
| ISPPGNQTCGASSNC | 716 | Q5THK1 | |
| NVSGSPQLCSSPDSS | 286 | Q5XKR4 | |
| ASNSIISCFNNAPPA | 26 | Q9Y2M0 | |
| NCNALTTCQDVPSPG | 181 | Q9BVN2 | |
| PASPAQVQSSQDGGC | 356 | Q8N1G1 | |
| SDSRSQPGQCCTDNP | 206 | Q9Y3M8 | |
| SPASSGASQETPNEC | 1006 | Q9UMZ2 | |
| PSVSDQPGEKENCSQ | 1301 | Q9UFD9 | |
| SQVAGAPSQCQAGTP | 211 | Q8IVL1 | |
| SGACTSQSRPPVQDQ | 306 | Q6P5W5 | |
| PSLNPLAQSQGLSCT | 746 | Q1XH10 | |
| NCEFSQPPESSQQGS | 341 | Q9ULL8 | |
| SAVQNTLCTGPSSQA | 36 | Q8TEV8 | |
| ANESCSNTAPSLTVP | 21 | Q9NTX7 | |
| STTGNQPEQGLSACT | 2001 | O75592 | |
| SQCVNQPEQLVSSAP | 251 | Q9H9Q4 | |
| NIDPSENSTSNLPNC | 81 | G3V0H7 | |
| EINEPCGNSTNLSPS | 836 | Q86SQ0 | |
| CGNSTNLSPSTQFPA | 841 | Q86SQ0 | |
| PRAGSPLCNSNLQDS | 971 | Q9NRY4 | |
| QDPGSTCPSFNTVRQ | 431 | P63128 | |
| PVQPLSSPQCNFSSD | 926 | Q8IWZ3 | |
| QIRTTATQENPSPNC | 206 | Q9BXN2 | |
| PNCPSSSSTNDFQAN | 996 | Q70EK8 | |
| QGSSESCTVNIPQQP | 821 | Q9C0B9 | |
| TSPQPASAGISQAQA | 941 | Q9C0B9 | |
| PEGSQNSLQAAPATT | 641 | O00562 | |
| GSPGQPCQSSSNDEE | 156 | Q8N2C7 | |
| SPINSQSRTCESPNQ | 246 | Q8N2C7 | |
| STLNSTGPSNPCQDD | 166 | Q9H3R2 | |
| PPSTQAPSVNGVCTD | 2131 | O15020 | |
| APSVNGVCTDGEPSQ | 2136 | O15020 | |
| LAPSQSQDSVNEPCS | 366 | O94804 | |
| SQDSVNEPCSQPSGD | 371 | O94804 | |
| NEPCSQPSGDRSLQT | 376 | O94804 | |
| QTPEASQASPCPAVT | 321 | Q9C0C2 | |
| DQQLQNGSCADPSPS | 406 | Q7L0X0 | |
| TAASNSCVQVNLPPS | 46 | Q96PS6 | |
| KSNVNQQCPASTPSS | 546 | Q9UF83 | |
| GNSTQCVISPSSEFP | 41 | Q71RS6 | |
| FQRPQSETNVASGCP | 371 | Q13077 | |
| EISNGLCGLNTSPSQ | 551 | Q9P0W8 | |
| ANPSCSITPITGNNS | 206 | Q569K4 | |
| TTSNATSNCQENPCP | 1066 | Q4KWH8 | |
| SRNPCKDSPASNSGQ | 181 | Q96JE7 | |
| PPTAAGESNSVTCNC | 801 | Q13472 | |
| PGSNNICDSDNPATE | 231 | Q6P444 | |
| GAGCISQPEQSSPES | 271 | Q8NAM6 | |
| TSSCLQGLPDNPDTQ | 2786 | Q96JG9 | |
| APGICTSPQSASQEN | 311 | Q9NZV7 | |
| ASSPQNVANSPTKEC | 801 | Q6PKC3 | |
| ATCNPNLNPEASSTR | 186 | Q9H869 | |
| PADSAISGQTSCPNN | 646 | Q8WYQ9 | |
| SQSTAINTVCGAPDP | 261 | A7E2V4 | |
| SPGCDSQTSQLDQPL | 2271 | Q96AY4 | |
| VSCPESGLGQSQAPA | 1016 | Q5SXM2 | |
| SQTECTSSNGQNPSP | 796 | Q9Y4F4 | |
| NNPEPEKCQSVSSAG | 566 | Q96RS0 | |
| SSCNPNPSGLNTKTT | 1676 | P31629 | |
| PSASVSNICPSNLNQ | 2441 | Q5T4S7 | |
| SDSGPVTQNCFISPE | 226 | Q9Y6X0 | |
| ENSVSPIGCNSSDPA | 2046 | Q5VUA4 | |
| NVNAVPPSSACNVSK | 1211 | Q9H2Y7 | |
| TDSKGCQPQPDATQV | 406 | Q9HCK0 | |
| SQRNASPNSEPCSSD | 536 | Q9P1Q0 | |
| AGVIAPGTPSQNTQC | 136 | O95407 | |
| QPSACLPTQAGTLSQ | 876 | Q70EL1 | |
| APGCQEQTANNPTES | 351 | A6NMK8 | |
| TQAQSSDQGPIAASP | 426 | Q8NFW9 |